To effectively utilize genomic testing and targeted therapies, the oncologist needs to correlate a patient's demographics and co-morbidities, evidence of cancer as observed in radiology studies and cause of cancer as observed in pathology and genomic tests.

Healthcare data is a powerful asset, with the potential to transform patient care and drive breakthroughs in personalized medicine, drug discovery, and disease prevention. Data monetization offers data custodians (Health Systems, Biobanks, Labs etc.) the opportunity to tap into this potential, generating new revenue streams while supporting advancements in medical research and innovation.

The adoption of genomic testing and targeted therapies in the clinical setting has not kept up with these innovations. Explore the system and oncologist specific barriers to adopting genomic testing and targeted therapies along with potential solutions to address these challenges.